NACL Industries Ltd
NACL is an established player and they deal in both technicals and formulations and they cater to the Indian market and to the international market as well. They have over 50 products covering all major crops. They have a strong logistic presence and the products are sold in more than 55,000 counters. NACL has become one of the reliable contract manufacturers for major MNCs. NACL exports products to over 30 countries and has forayed into International Brand business by registering brands in South-East Asia and Africa and are in the process of expanding reach in these regions.
- Market Cap ₹ 4,141 Cr.
- Current Price ₹ 177
- High / Low ₹ 265 / 113
- Stock P/E 105
- Book Value ₹ 31.4
- Dividend Yield 0.00 %
- ROCE 8.70 %
- ROE 5.18 %
- Face Value ₹ 1.00
Pros
Cons
- Stock is trading at 5.63 times its book value
- The company has delivered a poor sales growth of 4.82% over past five years.
- Company has a low return on equity of -7.15% over last 3 years.
- Promoter holding has decreased over last 3 years: -10.2%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE Commodities BSE 1000
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 746 | 691 | 734 | 846 | 865 | 1,015 | 1,191 | 1,633 | 2,116 | 1,781 | 1,252 | 1,507 | 1,451 | |
| 701 | 635 | 678 | 797 | 852 | 946 | 1,078 | 1,492 | 1,920 | 1,774 | 1,318 | 1,416 | 1,351 | |
| Operating Profit | 44 | 56 | 56 | 49 | 14 | 69 | 113 | 141 | 196 | 6 | -66 | 91 | 100 |
| OPM % | 6% | 8% | 8% | 6% | 1.6% | 7% | 10% | 9% | 9% | 0.4% | -5% | 6% | 7% |
| 26 | 18 | 41 | 19 | 26 | 7 | 15 | 16 | 12 | 10 | 39 | -3 | -2 | |
| Interest | 35 | 37 | 38 | 33 | 34 | 29 | 29 | 30 | 44 | 60 | 49 | 37 | 33 |
| Depreciation | 25 | 27 | 28 | 20 | 20 | 24 | 25 | 25 | 26 | 18 | 19 | 21 | 23 |
| Profit before tax | 10 | 11 | 31 | 15 | -15 | 23 | 74 | 102 | 138 | -62 | -96 | 30 | 42 |
| Tax % | 27% | 17% | -4% | 26% | -44% | 31% | 32% | 26% | 25% | -24% | -24% | 24% | |
| 8 | 9 | 32 | 11 | -8 | 16 | 50 | 76 | 103 | -47 | -73 | 23 | 32 | |
| EPS in Rs | 0.42 | 0.50 | 1.75 | 0.59 | -0.43 | 0.70 | 2.21 | 3.30 | 4.45 | -2.03 | -3.13 | 0.97 | 1.37 |
| Dividend Payout % | 20% | 17% | 6% | 18% | 0% | 12% | 16% | 14% | 14% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 5% |
| 3 Years: | -11% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | -9% |
| 3 Years: | -33% |
| TTM: | 157% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 26% |
| 3 Years: | 35% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 2% |
| 3 Years: | -7% |
| Last Year: | 5% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 16 | 16 | 16 | 16 | 17 | 19 | 20 | 20 | 20 | 20 | 20 | 23 |
| Reserves | 161 | 168 | 210 | 219 | 262 | 331 | 392 | 464 | 558 | 507 | 441 | 712 |
| 228 | 232 | 213 | 237 | 210 | 268 | 202 | 446 | 580 | 648 | 281 | 312 | |
| 260 | 193 | 209 | 237 | 248 | 330 | 354 | 486 | 595 | 494 | 386 | 334 | |
| Total Liabilities | 664 | 609 | 648 | 709 | 737 | 948 | 968 | 1,415 | 1,752 | 1,669 | 1,128 | 1,381 |
| 176 | 167 | 163 | 158 | 141 | 191 | 191 | 209 | 212 | 238 | 240 | 256 | |
| CWIP | 12 | 6 | 7 | 5 | 21 | 42 | 35 | 21 | 40 | 26 | 28 | 16 |
| Investments | 10 | 10 | 5 | 5 | 9 | 9 | 30 | 78 | 107 | 114 | 114 | 269 |
| 466 | 426 | 473 | 541 | 566 | 706 | 712 | 1,107 | 1,393 | 1,290 | 745 | 839 | |
| Total Assets | 664 | 609 | 648 | 709 | 737 | 948 | 968 | 1,415 | 1,752 | 1,669 | 1,128 | 1,381 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 | 46 | 59 | 24 | 36 | 103 | 84 | -116 | -10 | 26 | 449 | -104 | |
| -18 | -12 | -6 | -14 | -27 | -97 | -17 | -111 | -74 | -38 | 18 | -129 | |
| -27 | -33 | -58 | -11 | -9 | 70 | -84 | 204 | 79 | 4 | -410 | 235 | |
| Net Cash Flow | -4 | 1 | -5 | -1 | 0 | 77 | -17 | -22 | -5 | -8 | 57 | 2 |
| Free Cash Flow | 24 | 34 | 52 | 11 | 14 | 33 | 69 | -166 | -58 | -5 | 422 | -130 |
| CFO/OP | 96% | 86% | 110% | 66% | 287% | 153% | 83% | -63% | 9% | 671% | -679% | -121% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 108 | 99 | 110 | 124 | 113 | 129 | 103 | 118 | 133 | 160 | 91 | 113 |
| Inventory Days | 138 | 153 | 189 | 143 | 144 | 90 | 106 | 132 | 117 | 91 | 100 | 93 |
| Days Payable | 121 | 89 | 127 | 129 | 134 | 146 | 128 | 120 | 113 | 85 | 109 | 89 |
| Cash Conversion Cycle | 125 | 163 | 172 | 137 | 123 | 73 | 82 | 130 | 137 | 166 | 83 | 118 |
| Working Capital Days | 0 | 24 | 42 | 39 | 47 | 7 | 50 | 45 | 41 | 24 | 1 | 37 |
| ROCE % | 11% | 12% | 10% | 11% | 4% | 9% | 17% | 17% | 18% | -0% | -8% | 9% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ethakota Formulation Unit Production MT/KL |
|
||||||||||
| Permanent Employees count |
|||||||||||
| Srikakulam Technical Plant Production MT |
|||||||||||
| Dealer/Distributor Count count |
|||||||||||
| Total Product Registrations (India + Export) count |
|||||||||||
| Countries Exported To count |
|||||||||||
| Branded Products count |
|||||||||||
| R&D Expenditure (Percentage of Turnover) % |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- NACL Industries Limited has informed the Stock Exchange about News paper publication.
-
NACL Industries Limited Has informeds About Update On Sale Of Stake In Associate Company.
- Executed share purchase agreement on August 10, 2026 to divest equity in Nasense Labs Private Limited.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Quarter ended June 30, 2026 rights issue: no deviation; Rs24,928.92 lakh proceeds mostly utilized, Rs2,445 lakh in FD.
- NACL
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- NACL Industries Limited has informeds about the News Paper Publication.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Concalls
-
Feb 2024TranscriptAI SummaryPPT
-
Jan 2024TranscriptAI SummaryPPT
-
Sep 2023TranscriptAI SummaryPPT
-
Jun 2023TranscriptAI SummaryPPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022TranscriptAI SummaryPPT
-
May 2022TranscriptAI SummaryPPT
-
Jan 2022TranscriptAI SummaryPPT
-
Jan 2022TranscriptAI SummaryPPT
-
Nov 2021TranscriptAI SummaryPPT
-
Aug 2021TranscriptAI SummaryPPT
-
Jun 2021TranscriptAI SummaryPPT
-
Mar 2021TranscriptAI SummaryPPT
-
Dec 2020TranscriptAI SummaryPPT
Change of Promoter[1] [2]
Coromandel International Ltd has acquired a 53% controlling stake in NACL Industries Limited through agreements with existing promoters and other shareholders, along with the mandatory open offer, resulting in Coromandel becoming its promoter from Aug 2025. The open offer to acquire an additional 26% stake from public shareholders is still underway as per SEBI regulations.